InMed Pharmaceuticals Inc. (INM) Q4 2022 Earnings Call Transcript

InMed Pharmaceuticals Inc. (NASDAQ:INM) Q4 2022 Results Conference Call September 23, 2022 1:00 PM ET

Company Participants

Colin Clancy - VP, IR
Eric Adams - President and CEO
Michael Woudenberg - COO
Brenda Edwards - Interim CFO
Dr. Eric Hsu - SVP, Preclinical Research and Development

Conference Call Participants

Scott Henry - ROTH Capital Partners
Raghuram Selvaraju - H.C. Wainwright

Operator

Good day. And thank you for standing by. Welcome to InMed Pharmaceuticals Fourth Quarter Fiscal 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, Colin Clancy, Vice President of Investor Relations. Please go ahead.

Colin Clancy

Thank you, Norma, and good day, ladies and gentlemen. My name is Colin Clancy, InMed's Vice President of Investor Relations. Welcome to InMed's fiscal year-end 2022 financial results and business update conference call. Please note, our speakers are joining us today from remote locations, so we appreciate your patience if we encounter any unexpected technical challenges.

Before we begin, we would like to go over our disclosure statements, followed by a progress report on our pharmaceutical drug development program, led by our President and CEO, Eric Adams, together with update on our health and wellness commercial activities which will be provided by Michael Woudenberg, our Chief Operating Officer. Ms. Brenda Edwards, our interim Chief Financial Officer will then review the financial results of operations. Following that, we will be available for question-and-answer session. Also joining us today to address your questions is Dr. Eric Hsu, Senior Vice President of Preclinical Research and Development.

Please be advised that certain statements in